Class information for:
Level 1: NEWCASTLE DISEASE VIRUS//ACTIVE SPECIFIC IMMUNOTHERAPY ASI//ACTIVE SPECIFIC IMMUNOTHERAPY

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
17208 611 42.0 72%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
10 3       IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL 134299
140 2             IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY 23462
17208 1                   NEWCASTLE DISEASE VIRUS//ACTIVE SPECIFIC IMMUNOTHERAPY ASI//ACTIVE SPECIFIC IMMUNOTHERAPY 611

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 NEWCASTLE DISEASE VIRUS authKW 393246 12% 11% 73
2 ACTIVE SPECIFIC IMMUNOTHERAPY ASI authKW 249874 1% 100% 5
3 ACTIVE SPECIFIC IMMUNOTHERAPY authKW 246008 3% 31% 16
4 CELLULAR IMMUNOL D010 address 199899 1% 100% 4
5 TUMOR CELL VACCINES authKW 179904 1% 60% 6
6 VIRAL ONCOLYSATE authKW 159918 1% 80% 4
7 AF2240 authKW 149924 0% 100% 3
8 MTH 68 H authKW 149924 0% 100% 3
9 VACCINIA MELANOMA ONCOLYSATE authKW 149924 0% 100% 3
10 CELLULAR IMMUNOL address 131867 8% 5% 51

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 8025 59% 0% 359
2 Medicine, Research & Experimental 1063 16% 0% 100
3 Immunology 785 18% 0% 113
4 Virology 505 7% 0% 45
5 Biotechnology & Applied Microbiology 113 7% 0% 44
6 Surgery 55 7% 0% 45
7 Radiology, Nuclear Medicine & Medical Imaging 31 4% 0% 25
8 Genetics & Heredity 24 4% 0% 25
9 Pharmacology & Pharmacy 23 6% 0% 39
10 Dermatology 17 2% 0% 11

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CELLULAR IMMUNOL D010 199899 1% 100% 4
2 CELLULAR IMMUNOL 131867 8% 5% 51
3 ABT 0710 99950 0% 100% 2
4 ABT ZELLULARE IMMUNOL G0100 99950 0% 100% 2
5 BIOPHARMACEUT TEACHING 99950 0% 100% 2
6 ABT ZELLULARE IMMUNOL 66632 0% 67% 2
7 ABT DERMTOL 49975 0% 100% 1
8 BIOCHEMCHANOCK VIROL 49975 0% 100% 1
9 CANC PHYS 49975 0% 100% 1
10 CIRUGIA GEN MASTOL 49975 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS 21388 4% 2% 25
2 CANCER IMMUNOLOGY IMMUNOTHERAPY 14890 6% 1% 36
3 INTERNATIONAL JOURNAL OF ONCOLOGY 9231 7% 0% 42
4 JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS 3682 1% 1% 6
5 CANCER BIOTHERAPY 2100 0% 2% 2
6 YAKHTEH 1384 0% 1% 2
7 CANCER GENE THERAPY 1238 1% 0% 7
8 CANCER AND METASTASIS REVIEWS 1018 1% 0% 5
9 SEMINARS IN SURGICAL ONCOLOGY 922 1% 0% 4
10 TECHNOLOGY IN CANCER RESEARCH & TREATMENT 787 1% 0% 4

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 NEWCASTLE DISEASE VIRUS 393246 12% 11% 73 Search NEWCASTLE+DISEASE+VIRUS Search NEWCASTLE+DISEASE+VIRUS
2 ACTIVE SPECIFIC IMMUNOTHERAPY ASI 249874 1% 100% 5 Search ACTIVE+SPECIFIC+IMMUNOTHERAPY+ASI Search ACTIVE+SPECIFIC+IMMUNOTHERAPY+ASI
3 ACTIVE SPECIFIC IMMUNOTHERAPY 246008 3% 31% 16 Search ACTIVE+SPECIFIC+IMMUNOTHERAPY Search ACTIVE+SPECIFIC+IMMUNOTHERAPY
4 TUMOR CELL VACCINES 179904 1% 60% 6 Search TUMOR+CELL+VACCINES Search TUMOR+CELL+VACCINES
5 VIRAL ONCOLYSATE 159918 1% 80% 4 Search VIRAL+ONCOLYSATE Search VIRAL+ONCOLYSATE
6 AF2240 149924 0% 100% 3 Search AF2240 Search AF2240
7 MTH 68 H 149924 0% 100% 3 Search MTH+68+H Search MTH+68+H
8 VACCINIA MELANOMA ONCOLYSATE 149924 0% 100% 3 Search VACCINIA+MELANOMA+ONCOLYSATE Search VACCINIA+MELANOMA+ONCOLYSATE
9 NEWCASTLE DISEASE VIRUS NDV 119044 1% 26% 9 Search NEWCASTLE+DISEASE+VIRUS+NDV Search NEWCASTLE+DISEASE+VIRUS+NDV
10 AUTOLOGOUS TUMOR CELL LINES 99950 0% 100% 2 Search AUTOLOGOUS+TUMOR+CELL+LINES Search AUTOLOGOUS+TUMOR+CELL+LINES

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 ZAMARIN, D , PALESE, P , (2012) ONCOLYTIC NEWCASTLE DISEASE VIRUS FOR CANCER THERAPY: OLD CHALLENGES AND NEW DIRECTIONS.FUTURE MICROBIOLOGY. VOL. 7. ISSUE 3. P. 347 -367 86 55% 44
2 SCHIRRMACHER, V , (2015) ONCOLYTIC NEWCASTLE DISEASE VIRUS AS A PROSPECTIVE ANTI-CANCER THERAPY. A BIOLOGIC AGENT WITH POTENTIAL TO BREAK THERAPY RESISTANCE.EXPERT OPINION ON BIOLOGICAL THERAPY. VOL. 15. ISSUE 12. P. 1757 -1771 70 71% 0
3 LAM, HY , YEAP, SK , RASOLI, M , OMAR, AR , YUSOFF, K , SURAINI, AA , ALITHEEN, NB , (2011) SAFETY AND CLINICAL USAGE OF NEWCASTLE DISEASE VIRUS IN CANCER THERAPY.JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. VOL. . ISSUE . P. - 54 76% 18
4 SCHIRRMACHER, V , (2005) CLINICAL TRIALS OF ANTITUMOR VACCINATION WITH AN AUTOLOGOUS TUMOR CELL VACCINE MODIFIED BY VIRUS INFECTION: IMPROVEMENT OF PATIENT SURVIVAL BASED ON IMPROVED ANTITUMOR IMMUNE MEMORY.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 54. ISSUE 6. P. 587-598 38 70% 60
5 BAI, FL , TIAN, H , YU, QZ , REN, GP , LI, DS , (2015) EXPRESSING FOREIGN GENES BY NEWCASTLE DISEASE VIRUS FOR CANCER THERAPY.MOLECULAR BIOLOGY. VOL. 49. ISSUE 2. P. 171 -178 29 63% 1
6 ZHANG, CX , YE, LW , LIU, Y , XU, XY , LI, DR , YANG, YQ , SUN, LL , YUAN, J , (2015) ANTINEOPLASTIC ACTIVITY OF NEWCASTLE DISEASE VIRUS STRAIN D90 IN ORAL SQUAMOUS CELL CARCINOMA.TUMOR BIOLOGY. VOL. 36. ISSUE 9. P. 7121 -7131 26 70% 1
7 SCHIRRMACHER, V , GRIESBACH, A , AHLERT, T , (2001) ANTITUMOR EFFECTS OF NEWCASTLE DISEASE VIRUS IN VIVO: LOCAL VERSUS SYSTEMIC EFFECTS.INTERNATIONAL JOURNAL OF ONCOLOGY. VOL. 18. ISSUE 5. P. 945 -952 25 96% 40
8 ZHAO, LX , LIU, HY , (2012) NEWCASTLE DISEASE VIRUS: A PROMISING AGENT FOR TUMOUR IMMUNOTHERAPY.CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. VOL. 39. ISSUE 8. P. 725-730 30 61% 4
9 FU, F , ZHAO, M , YANG, YJ , TONG, GZ , YANG, BF , SONG, C , LI, X , (2011) ANTIPROLIFERATIVE EFFECT OF NEWCASTLE DISEASE VIRUS STRAIN D90 ON HUMAN LUNG CANCER CELL LINE A549.ONCOLOGY RESEARCH. VOL. 19. ISSUE 7. P. 323-333 19 95% 4
10 SCHIRRMACHER, V , HAAS, C , BONIFER, R , AHLERT, T , GERHARDS, R , ERTEL, C , (1999) HUMAN TUMOR CELL MODIFICATION BY VIRUS INFECTION: AN EFFICIENT AND SAFE WAY TO PRODUCE CANCER VACCINE WITH PLEIOTROPIC IMMUNE STIMULATORY PROPERTIES WHEN USING NEWCASTLE DISEASE VIRUS.GENE THERAPY. VOL. 6. ISSUE 1. P. 63 -73 25 86% 79

Classes with closest relation at Level 1


Rank Class id link
1 8124 TUMOR VACCINE//GENE THERAPY//B71
2 11429 CANCER IMMUNOLOGY IMMUNOTHERAPY//ANTITUMOR CYTOTOXIC LYMPHOCYTES//THYMIC IMMUNE REACTIVITY
3 1181 ONCOLYTIC VIRUS//ONCOLYTIC ADENOVIRUS//VIROTHERAPY
4 28487 ADJUVANT SPECIFIC IMMUNOTHERAPY//CHEMOTACTIC INHIBITORS//CHIMERIC ANTIBODY 311
5 4152 NEWCASTLE DISEASE VIRUS//NEWCASTLE DISEASE//AVIAN PARAMYXOVIRUS
6 32875 GEL FIBERGLASS//TERATOL EXPT ONCOL//KORET VET MED
7 6326 METASTATIC MELANOMA//BIOCHEMOTHERAPY//DACARBAZINE
8 13420 NG2 PROTEOGLYCAN//PERICYTE ENDOTHELIAL CELL INTERACTION//POLYVALENT ANTIGEN
9 13629 TUMOR IMMUNOL BIOL//SIPULEUCEL T//5T4
10 7508 TUMOR INFILTRATING LYMPHOCYTES//ADOPTIVE IMMUNOTHERAPY//TIL

Go to start page